⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1672540 | 0.75 | — | — | |
| SCHEMBL14697360 | 0.72 | — | — | |
| SCHEMBL1895595 | 0.69 | CHRM3 (0.32) | — | |
| SCHEMBL7265338 | 0.55 | — | — | |
| SCHEMBL2509681 | 0.47 | — | — | |
| SCHEMBL3151557 | 0.43 | — | — | |
| SCHEMBL4590762 | 0.42 | — | — | |
| SCHEMBL6718535 | 0.41 | — | — | |
| SCHEMBL4590897 | 0.37 | — | — | |
| SCHEMBL10638296 | 0.37 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250289781-A1 | TRIFLUOROMETHANESULFONYLATING AGENT COMPOSITION AND METHOD FOR PRODUCING TRIFLUOROMETHANESULFONYLOXY COMPOUND OR TRIFLUOROMETHANESULFONYL COMPOUND | CENTRAL GLASS COMPANY, LIMITED (JP) | 2025-09-18 | — | — | US | disclosed |
| CN-119137096-A | Trifluoromethanesulfonyl a composition of the agent trifluoromethanesulfonyl oxy compounds or Process for producing trifluoromethanesulfonyl compound | 中央硝子株式会社 | 2024-12-13 | — | — | CN | disclosed |
| WO-2023214552-A1 | TRIFLUOROMETHANE SULFONYLATION AGENT COMPOSITION AND METHOD FOR PRODUCING TRIFLUOROMETHANESULFONYLOXY COMPOUND OR TRIFLUOROMETHANE SULFONYL COMPOUND | セントラル硝子株式会社 | 2023-11-09 | — | — | WO | disclosed |
| WO-2022140224-A1 | 1H-PYRROLO[2,3-B]PYRIDINE DERIVATIVES AS BCL-2 INHIBITORS FOR THE TREATMENT OF NEOPLASTIC AND AUTOIMMUNE DISEASES | NEWAVE PHARMACEUTICAL INC. (US) | 2022-06-30 | — | — | WO | disclosed |
| EP-3468973-A1 | SOLID FORMS OF VENETOCLAX AND PROCESSES FOR THE PREPARATION OF VENETOCLAX | Dr. Reddy's Laboratories Ltd. (IN) | 2019-04-17 | — | — | EP | disclosed |
| EP-3464295-A1 | TRICYCLIC HETEROCYLIC DERIVATIVES | Merck Patent GmbH (DE) | 2019-04-10 | — | — | EP | disclosed |
| WO-2017212431-A1 | SOLID FORMS OF VENETOCLAX AND PROCESSES FOR THE PREPARATION OF VENETOCLAX | DR. REDDY’S LABORATORIES LIMITED (IN) | 2017-12-14 | — | — | WO | disclosed |
| WO-2017202748-A1 | TRICYCLIC HETEROCYLIC DERIVATIVES | MERCK PATENT GMBH (DE) | 2017-11-30 | — | — | WO | disclosed |
| WO-2008079909-A1 | PYRROLO [2,3-B] PYRIDINES AS KINASE MODULATORS | PLEXXIKON, INC. (US) | 2008-07-03 | — | — | WO | disclosed |
| EP-1794159-A1 | 7-AZAINDOLES AND THEIR USE AS PPAR AGONISTS | Sanofi-Aventis Deutschland GmbH (DE) | 2007-06-13 | — | — | EP | disclosed |
| WO-2006029699-A1 | 7-AZAINDOLES AND THEIR USE AS PPAR AGONISTS | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2006-03-23 | — | — | WO | disclosed |